Antibody-drug conjugates (ADCs) represent a promising class of targeted cancer therapeutics that combine the specificity of monoclonal antibodies with the potency of cytotoxic payloads. Despite their therapeutic potential, the use of ADCs faces significant challenges, including off/on-target toxicity and resistance development. This review examines the current landscape of ADC development, focusing on the critical aspects of target selection and antibody engineering. We discuss strategies to increase ADC efficacy and safety, including multitarget approaches, pH-dependent antibodies, and masked peptide technologies. The importance of comprehensive antigen expression profiling in both tumor and normal tissues is emphasized, highlighting the role of advanced technologies, such as single-cell sequencing and artificial intelligence, in optimizing target selection. Furthermore, we explore combination therapies and innovations in linker‒payload chemistry, which may provide approaches for expanding the therapeutic window of ADCs. These advances pave the way for the development of more precise and effective cancer treatments, potentially extending ADC applications beyond oncology.
Humans ; Immunoconjugates/adverse effects* ; Neoplasms/immunology* ; Animals ; Antibodies, Monoclonal/therapeutic use* ; Antineoplastic Agents/therapeutic use*

Objective To investigate the status and needs of training medical staff in county-level medical institutions in Guangxi to provide preferences for developing training programs. Methods Self-designed questionnaires were used to investigate a random sample of 477 medical staffs in 9 county-level medical institutions including People's Hospi-tals, Chinese Medical Hospitals, Maternity and Child Care Hospitals in Wuming, Liujiang, Rongxian counties. Re-sults 13% of the medical staffs had never participated in training; 28.1% of them were trained once a month; 50.7% of them were trained for less than a week. 39.4% of them expected to receive training once a year , 21.6% expected a week to half a month and 21.8% expected three months to six months. 60.4% of them expected to receive new knowl-edge and technique training. 73.6%of them expected to go to provincial hospitals for training and 57% of them expect-ed to receive extension study. Conclusion There are differences between medical staff training needs and status. Exist-ing questions are incomplete training coverage, too dense training frequency ,too short training period, medical staffs urgently need the training of continuing professional development, new technology and professional knowledge, and training effect is not obvious. We can establish medical staff in-service training incentives ,increase medical staffing and reform training methods to encourage and attract more medical staff to attend training.

0.05).After treatment for 7 days,TNF-a and IL-6 levels decreased in the medication groups(P